Day 2 ASH: Transplant is still a promising treatment, but MRD is King

Jack Aiello |

Today began with watching ASH abstract presentations from yesterday.  This is actually one of the benefits of attending the meeting virtually. Presentations are often scheduled at the same time and at the in-person meeting, you need to make a decision which to attend.  But being virtual, I’m able to watch a replay of a session […]

We’re In Good Hands

Valarie Traynham |

Although the 62nd American Society of Hematology meetings did not officially kick off until this morning, I had the opportunity to attend three of the pre-ASH Symposiums held yesterday. This is one advantage of the virtual platform that I appreciate. Each of the symposiums offered informative panel discussions with some of the best myeloma doctors […]